Holy Smoke
People with HIV in care smoke at twice the rate of the general population.

Dolutegravir vs. Raltegravir
A Phase III study compares the two integrase inhibitors.

Baby Cured
of HIV?
Data presented at CROI show a child born with HIV and treated with ARVs has been "functionally cured."

Trial Update
Boehringer Ingelhiem's Phase III clinical trial shows 80 percent early success rate for HCV protease inhibitor faldaprevir.

PrEP Progress
Long-acting PrEP injection prevents
anal transmission
of simian HIV.

The Hep C Pipeline
Second-generation antiviral hep C therapies show high cure rates in people who previously failed therapy.

PrEP Trials
for Women
Questions remain after interventions fail to protect from HIV.

Lowering "Bad" Cholesterol
Studies show statin med Livalo is more effective at lowering LDL cholesterol in HIV-positive adults.

Sex and the City
Gay and bisexual men in urban areas are more aware of their HIV status but prevalence holds steady.

Promising Start
A small early trial shows Merck's NNRTI MK-1439 is safe and well tolerated.

Wrapping It Up
Using condoms consistently for anal sex prevents HIV transmission 70% of the time.

Easing Inflammation
ARVs reduce cellular inflammation among elite controllers
of HIV.